CN101843744B - Traditional Chinese medicine for treating chronic renal failure - Google Patents

Traditional Chinese medicine for treating chronic renal failure Download PDF

Info

Publication number
CN101843744B
CN101843744B CN2009102383144A CN200910238314A CN101843744B CN 101843744 B CN101843744 B CN 101843744B CN 2009102383144 A CN2009102383144 A CN 2009102383144A CN 200910238314 A CN200910238314 A CN 200910238314A CN 101843744 B CN101843744 B CN 101843744B
Authority
CN
China
Prior art keywords
radix
chinese medicine
parts
renal failure
chronic renal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2009102383144A
Other languages
Chinese (zh)
Other versions
CN101843744A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qidong Huilong Vientiane Garden
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102383144A priority Critical patent/CN101843744B/en
Publication of CN101843744A publication Critical patent/CN101843744A/en
Application granted granted Critical
Publication of CN101843744B publication Critical patent/CN101843744B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A traditional Chinese medicine for curing chronic renal failure belongs to the traditional Chinese medicine field for curing urinary system diseases; the purpose is good effect and quick effect; the invention is prepared by adopting raw materials such as Chinese lobelia, monkshood, lucid ganoderma, pseudo-ginseng, radix rehmanniae, tuckahoe, largehead atractylodes rhizome, rhubarb, angelica and the like; the Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, warming kidney and tonifying yang, and tonifying spleen and dissolving turbidity, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

A kind of Chinese medicine of treating chronic renal failure
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of urinary system.
Background technology
The present field of Chinese medicines that is intended to treat chronic renal failure, have the shortcoming of several aspects: one of which, effect are obvious inadequately; Its two, it is slower to take effect.Day is not moved back oliguria even anuria to large quantities of patients for a long time because of medicine can not be alleviated the distinctive edema of renal failure effectively; Inappetence, indigestion and loss of appetite, abdominal distention, renal function are badly damaged.Patient and family members thereof are very dissatisfied.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating chronic renal failure, and it can solve, and this type of Chinese medicine effect was obvious inadequately in the past; The slower problem that takes effect, effective, instant effect; It is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating chronic renal failure adopts the raw material of Chinese medicine preparation, fill a prescription into (by weight):
Herba Lobeliae Chinensis 4-30 part Radix Aconiti Lateralis Preparata 4-30 part Ganoderma 2-12 part
Radix Notoginseng 3-20 part Radix Rehmanniae 4-30 part Poria 4-30 part
Rhizoma Atractylodis Macrocephalae 4-30 part Radix Et Rhizoma Rhei 3-20 part Radix Angelicae Sinensis 4-30 part
The Chinese medicine of this treatment chronic renal failure is processed by following method:
(1) by above-mentioned weight ratio, Herba Lobeliae Chinensis, Radix Aconiti Lateralis Preparata, the Radix Rehmanniae, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Et Rhizoma Rhei, Radix Angelicae Sinensis are extracted through conventional water extraction process, process the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The traditional Chinese medical science thinks that chronic renal failure has deficiency of spleen-YANG and kidneyYANG more, controls suitable warming YANG and invigorating QI, and spleen invigoratingization is turbid, blood circulation promoting and blood stasis dispelling.Radix Aconiti Lateralis Preparata warming YANG in the side; The Ganoderma QI invigorating; The Rhizoma Atractylodis Macrocephalae, Poria spleen invigorating; Being aided with Radix Et Rhizoma Rhei rushes down turbid; The Herba Lobeliae Chinensis dampness removing; The Radix Rehmanniae, Radix Angelicae Sinensis, Radix Notoginseng nourshing blood and promoting blood circulation blood stasis dispelling strengthen the nephridial tissue microcirculation.All medicine compatibilities bring out the best in each other, and have the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, warming the kidney to activate YANG, the merit that spleen invigoratingization is turbid, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Lobeliae Chinensis 80 gram Radix Aconiti Lateralis Preparatas 80 kairine sesames 40 grams
The Radix Notoginseng 60 gram Radix Rehmanniae 80 gram Poria 80 grams
The Rhizoma Atractylodis Macrocephalae 80 gram Radix Et Rhizoma Rhei 60 gram Radix Angelicae Sinensis 80 grams
Press predetermined weight, Herba Lobeliae Chinensis, Radix Aconiti Lateralis Preparata, the Radix Rehmanniae, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Et Rhizoma Rhei, Radix Angelicae Sinensis are extracted, process extractum fine powder 162 grams with conventional water extraction process; Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder; Process fine particle; Adorn capsule No. 0, process 935 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Herba Lobeliae Chinensis 160 gram Radix Aconiti Lateralis Preparatas 160 kairine sesames 60 grams
The Radix Notoginseng 100 gram Radix Rehmanniae 160 gram Poria 160 grams
The Rhizoma Atractylodis Macrocephalae 160 gram Radix Et Rhizoma Rhei 100 gram Radix Angelicae Sinensis 160 grams
By above-mentioned same method, process 1707 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Herba Lobeliae Chinensis 300 gram Radix Aconiti Lateralis Preparatas 300 kairine sesames 120 grams
The Radix Notoginseng 200 gram Radix Rehmanniae 300 gram Poria 300 grams
The Rhizoma Atractylodis Macrocephalae 300 gram Radix Et Rhizoma Rhei 200 gram Radix Angelicae Sinensis 300 grams
By above-mentioned same method, process 3285 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
3 parts of 6 portions of Ganodermas of 6 parts of Radix Aconiti Lateralis Preparatas of Herba Lobeliae Chinensis
6 parts in 6 parts of Poria of 4 parts of Radix Rehmanniae of Radix Notoginseng
6 parts of 4 parts of Radix Angelicae Sinensis of 6 parts of Radix Et Rhizoma Rhei of the Rhizoma Atractylodis Macrocephalae
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
10 parts of 25 portions of Ganodermas of 25 parts of Radix Aconiti Lateralis Preparatas of Herba Lobeliae Chinensis
25 parts in 25 parts of Poria of 15 parts of Radix Rehmanniae of Radix Notoginseng
25 parts of 15 parts of Radix Angelicae Sinensis of 25 parts of Radix Et Rhizoma Rhei of the Rhizoma Atractylodis Macrocephalae
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is example with the chronic renal failure, through 6 clinical observations.Selecting the tcm diagnosis chronic renal failure is standard: the chronic nephritis protracted course of disease, have a delicate constitution, and seriously weak; Day does not move back for a long time for anemia, oliguria even anuria, edema; Obstacle appears in digestive system, nausea,vomiting,diarrhea etc., and renal function is badly damaged.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 3 examples, women's 3 examples do not have other serious disease, and the age is 59 years old-81 years old, 69.5 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Anemia, edema are obviously alleviated; Oliguria, anuria situation are improved; Nausea,vomiting,diarrheas etc. are obviously alleviated.
2, effective: body constitution strengthens, on one's body energetically; Disease such as anemia, edema is alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 6 months after, symptom is obviously improved.6 philtrums of clinical experiment, produce effects 3 people, effective 2 people, invalid 1 people, total effective rate 83.3%.

Claims (1)

1. a Chinese medicine of treating chronic renal failure is characterized in that, said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Lobeliae Chinensis 4---12 parts of 30 parts of Radix Aconiti Lateralis Preparatas 4---30 portions of Ganodermas 2---
Radix Notoginseng 3---30 parts in 20 parts of Radix Rehmanniae 4---30 parts of Poria 4---
The Rhizoma Atractylodis Macrocephalae 4---30 parts of 30 parts of Radix Et Rhizoma Rhei 3---20 parts of Radix Angelicae Sinensis 4---
The Chinese medicine of this treatment chronic renal failure is processed by following method:
(1) by above-mentioned weight ratio, Herba Lobeliae Chinensis, Radix Aconiti Lateralis Preparata, the Radix Rehmanniae, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Et Rhizoma Rhei, Radix Angelicae Sinensis are extracted through conventional water extraction process, process the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder; Process Chinese medicine granules, capsule, watered pill, tablet.
CN2009102383144A 2009-11-18 2009-11-18 Traditional Chinese medicine for treating chronic renal failure Active CN101843744B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102383144A CN101843744B (en) 2009-11-18 2009-11-18 Traditional Chinese medicine for treating chronic renal failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102383144A CN101843744B (en) 2009-11-18 2009-11-18 Traditional Chinese medicine for treating chronic renal failure

Publications (2)

Publication Number Publication Date
CN101843744A CN101843744A (en) 2010-09-29
CN101843744B true CN101843744B (en) 2012-04-04

Family

ID=42768682

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102383144A Active CN101843744B (en) 2009-11-18 2009-11-18 Traditional Chinese medicine for treating chronic renal failure

Country Status (1)

Country Link
CN (1) CN101843744B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1360925A (en) * 2000-12-28 2002-07-31 张大宁 Chinese herbal medicine composition for treating chronic renal adynamia
CN1466962A (en) * 2002-07-11 2004-01-14 敏 徐 Method for processing aloe gelatin, aloe full-leaf gelatin and aloe skin gelatin
CN101085294A (en) * 2007-06-26 2007-12-12 北京艺信堂医药研究所 Traditional Chinese medicine for curing chronic renal failure

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1360925A (en) * 2000-12-28 2002-07-31 张大宁 Chinese herbal medicine composition for treating chronic renal adynamia
CN1466962A (en) * 2002-07-11 2004-01-14 敏 徐 Method for processing aloe gelatin, aloe full-leaf gelatin and aloe skin gelatin
CN101085294A (en) * 2007-06-26 2007-12-12 北京艺信堂医药研究所 Traditional Chinese medicine for curing chronic renal failure

Also Published As

Publication number Publication date
CN101843744A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843694B (en) Traditional Chinese medicine for treating chronic hepatitis
CN102048831A (en) Traditional Chinese medicine for treating cirrhosis
CN101843804A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN101406566B (en) Chinese medicine for treating gastric cancer
CN101843733B (en) Chinese medicament for treating ichthyosis
CN101396469B (en) Traditional Chinese medicine for treating diabetic nephrosis
CN101843744B (en) Traditional Chinese medicine for treating chronic renal failure
CN101843706B (en) Chinese medicament for treating chronic kidney failure
CN101850020B (en) Chinese medicament for treating chronic kidney failure
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN101390985B (en) Traditional Chinese medicine for treating diabetes acral necrosis
CN101850078B (en) Chinese medicament for treating chronic nephritis
CN101554426B (en) Traditional Chinese medicine for treating diabetic obstipation
CN101843717B (en) Chinese medicament for treating coronary disease
CN101843738A (en) Chinese medicament for treating diabetic feet
CN101843826B (en) Chinese medicament for treating chronic kidney failure
CN101843697B (en) Chinese medicament for treating chronic kidney failure
CN101843695B (en) Chinese medicament for treating chronic kidney failure
CN101843767A (en) Chinese medicament for treating chronic kidney failure
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101843756B (en) Chinese medicament for treating chronic nephritis
CN101843816B (en) Chinese medicament for treating chronic nephritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: QIDONG HUILONG WANXIANG FLOWER NURSERY

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20131108

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226299 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20131108

Address after: Qidong huilongzhen 54 226299 villages in Jiangsu province Nantong City Service Center (south side)

Patentee after: Qidong Huilong Vientiane Garden

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.